Unicycive Therapeutics Inc. (UNCY)
NASDAQ · Healthcare
Unicycive Therapeutics Inc. Operating Income 2022–2023
Unicycive Therapeutics Inc. annual/quarterly operating income history and growth rate from 2022 to 2023. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Unicycive Therapeutics Inc. operating income for the quarter ending March 31, 2023 was -4.2 M.
- Unicycive Therapeutics Inc. annual operating income for 2023 was -20.8 M, a 15.08% increase from 2022.
- Unicycive Therapeutics Inc. annual operating income for 2022 was -18.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Unicycive Therapeutics Inc. Operating Income — FAQ
Unicycive Therapeutics Inc. (UNCY) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Unicycive Therapeutics Inc.'s operating income?
Unicycive Therapeutics Inc. (UNCY) reported operating income of -$21M for fiscal 2023.
Where can I see UNCY's operating income history?
The chart and table above show Unicycive Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.